Document Detail


Clinical evaluation of new antitumor antibiotics.
MedLine Citation:
PMID:  81505     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The clinical evaluation of new antibiotics and their analogs requires detailed analysis with respect to the best therapeutic strategy. In the case of anthracycline, diminished cardiac toxicity is as important an aim as increased activity. In the evaluation of cardiac toxicity the most important parameter must be the time to toxicity rather than the total dose. The new endomyocardial biopsy technique may be helpful in the study of analogs such as rubidazone, carminomycin and AD32. Actinomycin D analogs are also of interest, since this drug is part of several curative regimens, but its use has been limited by its severe acute toxicity. In the case of bleomycin, analogs with diminished pulmonary toxicity should be sought.
Authors:
F M Muggia
Related Documents :
17239925 - Phototransformation products of tamoxifen by sunlight in water. toxicity of the drug an...
15051055 - Bioactivation of carbamate-based 20(s)-camptothecin prodrugs.
22052315 - Q-switched laser treatment of amiodarone pigmentation.
12678835 - Oxazolidinone antibacterial agents: a critical review.
16023805 - Exploiting gastrointestinal bacteria to target drugs to the colon: an in vitro study us...
1782485 - Liposomes in haematology.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer     Volume:  63     ISSN:  0080-0015     ISO Abbreviation:  Recent Results Cancer Res.     Publication Date:  1978  
Date Detail:
Created Date:  1978-12-29     Completed Date:  1978-12-29     Revised Date:  2008-02-13    
Medline Journal Info:
Nlm Unique ID:  0044671     Medline TA:  Recent Results Cancer Res     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  288-97     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibiotics, Antineoplastic / therapeutic use*
Bleomycin / analogs & derivatives,  therapeutic use
Dactinomycin / analogs & derivatives,  therapeutic use
Humans
Chemical
Reg. No./Substance:
0/Antibiotics, Antineoplastic; 11056-06-7/Bleomycin; 50-76-0/Dactinomycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Experimental results with the combination of bleomycin plus mitomycin C.
Next Document:  Antitumor antibiotic bioactivation, biotransformation and derivatization by microbial systems.